ampelopsin has been researched along with glucagon-like peptide 1 in 2 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | ampelopsin (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, H; Li, T; Mi, M; Wu, L; Xie, Y; Yi, L; Zhang, Q; Zhou, M | 1 |
| Li, X; Mou, H; Wei, L; Yang, X; Yao, Y | 1 |
2 other study(ies) available for ampelopsin and glucagon-like peptide 1
| Article | Year |
|---|---|
Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-4.
Topics: Animals; Fatty Acids, Volatile; Flavonols; Glucagon-Like Peptide 1; Mice | 2022 |
Dihydromyricetin promotes GLP-1 release and glucose uptake by STC-1 cells and enhances the effects of metformin upon STC-1 cells and diabetic mouse model.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Glucose; Hypoglycemic Agents; Insulin; Metformin; Tea | 2023 |